Sameer Ralhan - 01 Mar 2022 Form 4 Insider Report for Chemours Co (CC)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
03 Mar 2022, 07:53:45 UTC
Prior SEC filing
15 Feb 2022
Next SEC filing
09 May 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Pauletta Brown, Attorney-in-Fact

Key filing fact

Sameer Ralhan filed Form 4 for Chemours Co (CC) on 03 Mar 2022.

Key facts

  • This page summarizes Sameer Ralhan's Form 4 filing for Chemours Co (CC).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 03 Mar 2022, 07:53.

Change

  • Previous filing in this sequence was filed on 15 Feb 2022.
  • Current net transaction value: -$14,289.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CC transaction

Common Stock

Tax liability

Transaction value
$14,289
Shares
-550
Change %
-0.18%
Price
$25.98
Shares after
306,837
Date
01 Mar 2022
Ownership
Direct
Footnotes
F1, F2
CC transaction

Common Stock

Award

Transaction value
$0
Shares
+6,254
Change %
+2%
Price
$0.000000
Shares after
313,091
Date
01 Mar 2022
Ownership
Direct
Footnotes
F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CC transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+65,722
Change %
Price
$0.000000
Shares after
65,722
Date
01 Mar 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
65,722
Exercise price
$25.98
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold.

Footnote F2

Includes directly owned shares, restricted stock units and dividend equivalent units.

Footnote F3

Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2023.

Footnote F4

These options are scheduled to vest in three equal annual installments beginning on March 1, 2023.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .